Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5528Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Original Article | - |
| dc.date.accessioned | 2026-07-02T08:02:08Z | - |
| dc.date.available | 2026-07-02T08:02:08Z | - |
| dc.date.issued | 2026-07-02 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5528 | - |
| dc.description | Vol. 163, No. 1, p 88 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Hemoglobinopathies | en_US |
| dc.subject | Hydroxyurea therapy | en_US |
| dc.subject | Jharkhand | en_US |
| dc.subject | Registry | en_US |
| dc.subject | Sickle cell disease | en_US |
| dc.subject | Vaso-occlusive crisis | en_US |
| dc.title | Sickle cell disease in Jharkhand : A registry Based evaluation of disease burden and healthcare needs | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 163, No. 1, 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.